532 related articles for article (PubMed ID: 15166500)
1. The role of the fibrinolytic system in corneal angiogenesis.
Vogten JM; Reijerkerk A; Meijers JC; Voest EE; Borel Rinkes IH; Gebbink MF
Angiogenesis; 2003; 6(4):311-6. PubMed ID: 15166500
[TBL] [Abstract][Full Text] [Related]
2. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis.
Brodsky S; Chen J; Lee A; Akassoglou K; Norman J; Goligorsky MS
Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1784-92. PubMed ID: 11557572
[TBL] [Abstract][Full Text] [Related]
3. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.
Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ
Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781
[TBL] [Abstract][Full Text] [Related]
4. Irsogladine maleate inhibits angiogenesis in wild-type and plasminogen activator-deficient mice.
Ren CJ; Ueda F; Roses DF; Harris MN; Mignatti P; Rifkin DB; Shapiro RL
J Surg Res; 1998 Jul; 77(2):126-31. PubMed ID: 9733598
[TBL] [Abstract][Full Text] [Related]
5. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent.
Devy L; Blacher S; Grignet-Debrus C; Bajou K; Masson V; Gerard RD; Gils A; Carmeliet G; Carmeliet P; Declerck PJ; Nöel A; Foidart JM
FASEB J; 2002 Feb; 16(2):147-54. PubMed ID: 11818362
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes.
Lijnen HR; Wagner EF; Collen D
Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597
[TBL] [Abstract][Full Text] [Related]
7. Physiological consequences of loss of plasminogen activator gene function in mice.
Carmeliet P; Schoonjans L; Kieckens L; Ream B; Degen J; Bronson R; De Vos R; van den Oord JJ; Collen D; Mulligan RC
Nature; 1994 Mar; 368(6470):419-24. PubMed ID: 8133887
[TBL] [Abstract][Full Text] [Related]
8. Tissue type plasminogen activator facilitates NMDA-receptor-mediated retinal apoptosis through an independent fibrinolytic cascade.
Kumada M; Niwa M; Hara A; Matsuno H; Mori H; Ueshima S; Matsuo O; Yamamoto T; Kozawa O
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1504-7. PubMed ID: 15790922
[TBL] [Abstract][Full Text] [Related]
9. Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII.
Nielsen VG; Steenwyk BL; Gurley WQ
J Heart Lung Transplant; 2006 Oct; 25(10):1247-52. PubMed ID: 17045938
[TBL] [Abstract][Full Text] [Related]
10. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
Guimarães AH; Rijken DC
Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
[TBL] [Abstract][Full Text] [Related]
11. Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice.
Nagai N; De Mol M; Lijnen HR; Carmeliet P; Collen D
Circulation; 1999 May; 99(18):2440-4. PubMed ID: 10318667
[TBL] [Abstract][Full Text] [Related]
12. The role of fibrinolytic genes and proteins in the development of allograft vascular disease.
Benza RL; Passineau MJ; Anderson PG; Barchue JP; George JF
J Heart Lung Transplant; 2011 Aug; 30(8):935-44. PubMed ID: 21652221
[TBL] [Abstract][Full Text] [Related]
13. The role of the plasminogen system in bone resorption in vitro.
Daci E; Udagawa N; Martin TJ; Bouillon R; Carmeliet G
J Bone Miner Res; 1999 Jun; 14(6):946-52. PubMed ID: 10352103
[TBL] [Abstract][Full Text] [Related]
14. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
[TBL] [Abstract][Full Text] [Related]
15. Increased bone formation in mice lacking plasminogen activators.
Daci E; Everts V; Torrekens S; Van Herck E; Tigchelaar-Gutterr W; Bouillon R; Carmeliet G
J Bone Miner Res; 2003 Jul; 18(7):1167-76. PubMed ID: 12854826
[TBL] [Abstract][Full Text] [Related]
16. The interaction between components of the fibrinolytic system and GPIb/V/IX of platelets thrombus formation in mice.
Matsuno H; Kozawa O; Ueshima S; Matsuo O; Collen D; Uematsu T
Br J Pharmacol; 2000 Oct; 131(4):858-64. PubMed ID: 11030738
[TBL] [Abstract][Full Text] [Related]
17. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
18. TAFI and pancreatic carboxypeptidase B modulate in vitro capillary tube formation by human microvascular endothelial cells.
Guimarães AH; Laurens N; Weijers EM; Koolwijk P; van Hinsbergh VW; Rijken DC
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2157-62. PubMed ID: 17673703
[TBL] [Abstract][Full Text] [Related]
19. Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury.
Matsuno H; Kozawa O; Niwa M; Ueshima S; Matsuo O; Collen D; Uematsu T
Thromb Haemost; 1999 Apr; 81(4):601-4. PubMed ID: 10235447
[TBL] [Abstract][Full Text] [Related]
20. A role of fibrinolytic activity in angiogenesis. Quantitative assay using in vitro method.
Yasunaga C; Nakashima Y; Sueishi K
Lab Invest; 1989 Dec; 61(6):698-704. PubMed ID: 2481153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
